We help IT leaders and quality organizations for biotech companies navigate GxP compliance on Microsoft platforms. This article summarizes the realities of the regulations involved, what validation means under the FDA Computer Software Assurance approach, and how GxP should be achieved when working with Microsoft cloud services.
The truth is simple. Compliance for GxP involves running lab, clinical, and manufacturing systems in ways that make sure data generated can be trusted, attributed, and reviewed by regulators. For the US market, the digital aspect of GxP compliance is covered by 21 CFR Part 11, the FDA regulation that allows electronic records and signatures to replace paper and ink. Within a biotech company, the choice is stark. Get compliance right, or project timelines get derailed, FDA submissions compromised, and inspections turn into crisis response exercises. This piece tells you what matters.
What is GxP Compliance?
“Good Practices” are sets of rules defining how a particular regulated life sciences function should behave. GMP stands for Good Manufacturing Practice, GLP Good Laboratory Practice, GCP Good Clinical Practice, GDP Good Distribution Practice, and other acronyms depending on the agency jurisdiction. But every acronym has a shared goal: to ensure safety, efficacy, and integrity of records for the processes.
For an IT organization, GxP becomes relevant immediately upon the introduction of computerized systems used for regulated tasks. Those include instruments and informatics, quality management systems, manufacturing execution systems, and even communication and collaboration tools retaining any type of GxP record in digital format. Once you store information supporting a regulated decision-making process, that falls into GxP scope.
What is 21 CFR Part 11?
FDA regulation 21 CFR Part 11 lays out criteria for accepting electronic records and signatures as equivalent and reliable substitutes to paper records and handwritten signatures. It kicks in automatically whenever an FDA rule requires maintaining a set of regulated records electronically. Translation: if a dataset is maintained digitally, Part 11 applies.
The regulation breaks down into a handful of control areas. These are the ones your systems and procedures have to cover:
| Requirement | What it means in practice |
| Validation | Each system is validated to show it is accurate, reliable, and consistent, and that it can detect invalid or altered records. |
| Audit trails | Secure, time-stamped, computer-generated records capture who did what and when, without overwriting earlier entries, and are kept as long as the data itself. |
| Access controls | Only authorized people can use the system, and authority checks limit who can enter, change, or sign records. |
| Electronic signatures | Signatures are unique to one person, verified before issue, and linked to their records so they cannot be copied or moved to falsify data. |
| Accurate copies | The system can produce complete, readable copies of records in both human-readable and electronic form for inspection. |
| Record retention | Records stay accurate and readily retrievable for the full retention period required by the predicate rule. |
A common misconception is that software can be bought “Part 11 compliant” off the shelf. No product makes you compliant on its own. Part 11 compliance is a combination of system capabilities, how you configure them, and the procedures your people follow. The tool gives you the controls. You still have to switch them on, validate them, and operate them.
The Default Way to Demonstrate Correct Operation: CSV vs CSA
Until recently, the conventional way to establish correctness in operation of GxP systems involved Computer System Validation (CSV), aka validation. Properly performed CSV would have made teams confident. Most CSV implementations became a mountain of documents with scripted tests that proved nothing in practice except the skill of documentation generation. Every team had to spend equal resources, irrespective of risk level.
In September 2025, the FDA published Computer Software Assurance (CSA). Its core purpose remained the same: ensure that a system is fit for its purpose. But instead of a blanket process, CSA introduced risk awareness, asking teams to focus on risk first. High-risk components still receive rigorous scripted testing. Functions of lower risk might use unscripted verification and pre-existing vendor evidence. Documentation ceased becoming a goal unto itself.
| Dimension | Traditional CSV | Computer Software Assurance (CSA) |
| Starting point | Validate everything, document heavily | Assess risk first, then match effort to risk |
| Testing | Mostly scripted, uniform across functions | Scripted for high risk, unscripted or ad hoc for low risk |
| Documentation | Extensive, often the main deliverable | Right-sized, focused on evidence that reduces risk |
| Supplier evidence | Often re-tested in house | Leveraged where the supplier is credible |
| Mindset | Compliance by volume | Assurance by critical thinking |
For a biotech moving quickly, CSA is good news. It means you can bring a new quality or lab system into use faster, as long as you can show you understood the risks and tested accordingly. It does not mean less compliance. It means compliance aimed where it counts.
GAMP 5 and the Risk-Based Methodology
While CSA defines FDA guidance, GAMP 5 has become de facto industry-standard in implementing it. Published by ISPE, GAMP 5 gives instructions on designing, building, validating, deploying, and maintaining compliant systems with a risk-based methodology. Its second edition in 2022 reflected the CSA guidance directly. Software types are identified based on risk, validation efforts are adjusted to risks and complexity levels, and leveraging work already done by the vendor is explicitly encouraged. For IT biotech teams, GAMP 5 serves as implementation guidance on CSA.
Data Integrity and ALCOA+ Principles
Every GxP and Part 11 requirement stems from the fundamental principle of reliable data. This principle is formalized into the ALCOA+ guidelines, describing desirable traits of good data throughout its lifecycle.
– Attributable. Each modification of a record can be linked to a person and time.
– Legible. The record should be legible and durable both currently and in the future.
– Contemporaneous. Data capture happens simultaneously with an activity performed.
– Original. First recording of the data, or a verified duplicate.
– Accurate. Without any suspicious modifications.
– Plus complete, consistent, enduring, and available: nothing omitted, everything follows chronologically, stored until its retention expiration, and retrievable upon demand.
The typical source of data integrity issues discovered during an inspection is breaking these requirements. An unavailable audit trail, shared identity leading to unclear attribution, an uncontrolled spreadsheet containing lab results outside any compliant system. Effective IT controls prevent all of them.
Is Microsoft 365 or Azure GxP Compliant, and Why Does Anyone Care?
Cloud compliance continues confusing many biotech organizations, since the answer is nuanced enough for clarity. The statement by Microsoft itself clarifies matters best: “there is no GxP certification for cloud service providers.” Neither Azure nor Microsoft 365 services qualify as inherently “Part 11 compliant”. What is then?
Microsoft certifies its offerings via ISO 9001 and ISO/IEC 27001 and meets all GAMP and PIC/S guidelines. It publishes comprehensive guidelines for qualifying systems for GxP usage in its cloud platform. It leaves plenty of room to configure controls according to needs.
Cloud Compliance Responsibility Model: How It Works in Practice
With clear certification of the underlying platform in place, the responsibility shifts to a customer. Each GxP system deployed onto Microsoft cloud must be validated in accordance with CSA, configured for compliance with Part 11 requirements, and supported by procedures and documentation proving compliance. In practice, it involves setting up and verifying audit trails, restricting identity and accesses, managing electronic signatures, validating specific use cases for the product deployment.
When handled effectively, the platform infrastructure handles most tasks on behalf of IT teams. Managing a valid Microsoft 365 configuration with Azure Managed Services leaves all controls maintained and documented for audits rather than recreating at each review round. Even a migration of a validated legacy solution ensures continuity of the validation status, provided it was done in advance.
GxP Part 11 Compliance Checklist
Feel free to leverage this checklist as the readiness assessment for an upcoming audit or before introducing a new system for regulatory purposes. Your yes answer to each statement implies successful fulfillment of compliance requirements.
– Validation. All in-scope systems are validated for their intended use, documentation preserved.
– Audit Trails. Secure audit trails are enabled with timestamps, tamper-proofed, and stored together with the data they describe.
– Access Controls. All accounts use a unique identity and are limited only to roles and functions. No shared access is allowed.
– Signatures. Unique signatures, verified and traceable, attached to the records, showing date/time/meaning and creator name.
– Records Copies. Full copies of the record are available in both human-readable and machine-readable formats for inspectors.
– Retention. Records stored and accessible reliably until expiration of their retention period according to applicable regulation.
– Procedures. Procedures exist to govern use of each control, and users are properly trained to follow them.
Help From TrnDigital
Our biotech and life sciences team builds the IT infrastructure of compliant GxP organizations in the United States. The first step consists of evaluating what computerized systems you have within the scope, and configuring Part 11 controls for those systems hosted within Microsoft 365 and Azure environments. The second part is helping your quality organization transition away from CSV towards CSA. Finally, we preserve all documentation demonstrating compliance, including validation artifacts. Since we support Microsoft stacks continuously rather than sporadically before audits, we ensure all controls remain active and compliant at all times. Partnering with us delivers the benefit of an established validation and security capability without hiring dedicated staff.
Need to Clarify GxP Scope, Compliance Status, and Gap List for Your Organization? Schedule a consultation call!
FAQs About Part 11 Compliance, Cloud, CSA, and GxP
Is Microsoft 365 or Azure Part 11 Compliant?
Neither cloud nor any other type of technology is certified under FDA’s Part 11. Microsoft 365 and Azure have been qualified via appropriate certifications and guidelines. Customers must validate their deployments within the Microsoft ecosystem and configure Part 11 controls appropriately. Both Microsoft and customers share compliance responsibilities.
How is CSV Different From CSA?
Traditional CSV treated all software equally, performing rigorous validation across the entire scope of functionalities and producing extensive documentation. CSA divides functionality into high-risk, medium-risk, and low-risk, allowing relaxed validation for low-risk segments based on pre-existing vendor evidence. Focus stays on high-risk sections exclusively.
Is Part 11 Applicable to Cloud Systems and SaaS Solutions?
Yes, absolutely. All electronic records are subject to Part 11 regardless of their location and technology used. Cloud providers qualify infrastructure, while adopters must validate applications, configure controls, and maintain relevant documentation.
What Are ALCOA+ Data Integrity Principles?
Acronym ALCOA refers to desirable properties of compliant datasets: attributable, legible, contemporaneous, original, and accurate. Additional letters specify additional conditions for completeness, consistency, endurance, and availability. Violations of any ALCOA+ principle create data integrity findings for an inspection.
What is EU Annex 11, And Is It Similar to Part 11?
Annex 11 is European Good Manufacturing Practice for computerized systems. It parallels Part 11 in key concepts, covering validation and controls similar to Part 11 provisions. Many organizations meet both sets of requirements using identical controls and documentation templates.
When Should Systems Undergo Revalidation?
Revalidation follows any change impacting software, hardware, functional specifications, configuration, or intended usage scenario. Otherwise, revalidation occurs periodically as dictated by the risk profile of each system. Change control procedure maintains continuous validation status.
Conclusion
It bears repeating: GxP compliance and Part 11 do not obstruct rapid developments in the biotech industry. On the contrary, they are a safety net for making fast moves and keeping data reliable, submissions intact, and products safe. Identify what is in scope for compliance, validate it based on risk level, safeguard its integrity through proper controls, and manage cloud environments with a shared responsibility model. Inspections will become routine check-ups in consequence. At least, that is what partners like TrnDigital bring for organizations working within Microsoft space.
